Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANDU PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
TEVA PHARMA
Dec-13
SANDU PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs863,479-   
Low Rs503,022-   
Sales per share (Unadj.) Rs67.61,996.4-  
Earnings per share (Unadj.) Rs1.6124.7-  
Cash flow per share (Unadj.) Rs2.1286.1-  
Dividends per share (Unadj.) Rs0.75109.18-  
Avg Dividend yield %1.13.4 32.8%  
Book value per share (Unadj.) Rs40.62,217.6-  
Shares outstanding (eoy) m9.66848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.01.6 61.9%   
Avg P/E ratio x43.326.1 166.1%  
P/CF ratio (eoy) x32.311.4 284.4%  
Price / Book Value ratio x1.71.5 114.4%  
Dividend payout %47.687.5 54.4%   
Avg Mkt Cap Rs m6582,756,220 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1110-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m6531,692,969 0.0%  
Other income Rs m30-   
Total revenues Rs m6571,692,969 0.0%   
Gross profit Rs m25463,620 0.0%  
Depreciation Rs m5136,844 0.0%   
Interest Rs m133,253 0.0%   
Profit before tax Rs m22293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m7-3,584 -0.2%   
Profit after tax Rs m15105,758 0.0%  
Gross profit margin %3.827.4 13.9%  
Effective tax rate %31.4-1.2 -2,572.1%   
Net profit margin %2.36.2 37.2%  
BALANCE SHEET DATA
Current assets Rs m2551,143,425 0.0%   
Current liabilities Rs m139997,163 0.0%   
Net working cap to sales %17.88.6 206.6%  
Current ratio x1.81.1 160.5%  
Inventory Days Days6591 71.3%  
Debtors Days Days26896 279.1%  
Net fixed assets Rs m286552,961 0.1%   
Share capital Rs m974,167 2.3%   
"Free" reserves Rs m2960-   
Net worth Rs m3921,880,567 0.0%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m5423,868,976 0.0%  
Interest coverage x28.79.8 292.1%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 275.7%   
Return on assets %3.03.6 82.2%  
Return on equity %3.95.6 68.9%  
Return on capital %5.94.9 118.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m2269,772 0.0%  
From Investments Rs m5-95,591 -0.0%  
From Financial Activity Rs m6-323,609 -0.0%  
Net Cashflow Rs m13-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SANDU PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SANDU PHARMA With: AMRUTANJAN HEALTHCARE  ALCHEMIST LIMITED  WANBURY  WOCKHARDT  BERYL DRUGS  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.